David Jencks
NPI: 1700175635
Total Payments
$2,348
2024 Payments
$337.49
Companies
23
Transactions
70
Medicare Patients
5,384
Medicare Billing
$638,463
Payment Breakdown by Category
Food & Beverage$2,348 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,348 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $537.77 | 5 | $0 (2018) |
| ABBVIE INC. | $440.39 | 20 | $0 (2024) |
| Covidien LP | $290.84 | 4 | $0 (2018) |
| Ethicon Inc. | $221.09 | 1 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $137.46 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.67 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $89.23 | 5 | $0 (2022) |
| Boston Scientific Corporation | $83.46 | 1 | $0 (2024) |
| Braintree Laboratories, Inc. | $80.76 | 5 | $0 (2024) |
| BioFire Diagnostics, LLC | $68.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.49 | 13 | ABBVIE INC. ($88.27) |
| 2023 | $230.07 | 12 | ABBVIE INC. ($56.39) |
| 2022 | $308.50 | 13 | ABBVIE INC. ($157.20) |
| 2021 | $163.32 | 9 | AbbVie Inc. ($81.77) |
| 2020 | $57.01 | 3 | AbbVie Inc. ($23.60) |
| 2019 | $144.41 | 6 | BioFire Diagnostics, LLC ($68.05) |
| 2018 | $576.71 | 10 | Covidien LP ($290.84) |
| 2017 | $530.55 | 4 | Gilead Sciences Inc ($309.46) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Immunology | ||||||
| 08/26/2019 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 08/07/2019 | BioFire Diagnostics, LLC | BioFire FilmArray (Device) | Food and Beverage | Cash or cash equivalent | $68.05 | General |
| Category: Clinical Diagnostics | ||||||
| 07/23/2019 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 06/26/2019 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 04/25/2019 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $20.01 | General |
| Category: Elastography | ||||||
| 12/11/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Gastroenterology | ||||||
| 11/13/2018 | Covidien LP | Beacon (Device) | Food and Beverage | In-kind items and services | $192.30 | General |
| Category: GI Solutions | ||||||
| 11/13/2018 | Covidien LP | Beacon (Device) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: GI Solutions | ||||||
| 08/06/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Immunology | ||||||
| 08/01/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Immunology | ||||||
| 06/28/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $103.31 | General |
| Category: HCV | ||||||
| 06/20/2018 | Covidien LP | Beacon (Device) | Food and Beverage | In-kind items and services | $38.09 | General |
| Category: GI Solutions | ||||||
| 06/15/2018 | Covidien LP | Beacon (Device) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: GI Solutions | ||||||
| 04/25/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 12/12/2017 | Ethicon Inc. | LINX Reflux Management System (Device) | Food and Beverage | Cash or cash equivalent | $221.09 | General |
| Category: Endo-Mechanical | ||||||
| 09/05/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $101.85 | General |
| Category: HCV | ||||||
| 01/18/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $103.87 | General |
| Category: HCV | ||||||
| 01/10/2017 | Gilead Sciences Inc | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $103.74 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,271 | 1,379 | $902,950 | $154,717 |
| 2022 | 18 | 1,458 | 1,605 | $961,130 | $172,302 |
| 2021 | 20 | 1,420 | 1,621 | $904,108 | $169,128 |
| 2020 | 19 | 1,235 | 1,412 | $656,352 | $142,317 |
Total Patients
5,384
Total Services
6,017
Medicare Billing
$638,463
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 151 | 154 | $170,940 | $33,713 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 325 | $130,000 | $21,118 | 16.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 154 | 156 | $124,080 | $17,601 | 14.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 189 | 192 | $95,160 | $14,113 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 145 | $82,650 | $14,081 | 17.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 70 | 71 | $57,510 | $12,765 | 22.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 15 | 15 | $58,050 | $9,508 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $44,530 | $7,532 | 16.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 32 | 33 | $26,730 | $5,773 | 21.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 40 | 41 | $33,210 | $5,644 | 17.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $30,870 | $4,731 | 15.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 28 | 30 | $18,760 | $3,158 | 16.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 57 | $14,250 | $2,121 | 14.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $7,540 | $1,406 | 18.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $5,670 | $935.17 | 16.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $3,000 | $517.11 | 17.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 153 | 155 | $172,050 | $33,492 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 297 | 406 | $162,400 | $26,857 | 16.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 177 | 179 | $127,600 | $19,719 | 15.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 212 | 220 | $97,905 | $16,531 | 16.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 91 | $52,780 | $10,284 | 19.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 53 | 54 | $43,740 | $10,270 | 23.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 14 | 14 | $54,180 | $9,621 | 17.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 95 | 95 | $46,550 | $7,674 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $36,500 | $6,449 | 17.7% |
About David Jencks
David Jencks is a Student in an Organized Health Care Education/Training Program healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1700175635.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Jencks has received a total of $2,348 in payments from pharmaceutical and medical device companies, with $337.49 received in 2024. These payments were reported across 70 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,348).
As a Medicare-enrolled provider, Jencks has provided services to 5,384 Medicare beneficiaries, totaling 6,017 services with total Medicare billing of $638,463. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Annapolis, MD
- Active Since 03/31/2011
- Last Updated 07/23/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1700175635
Products in Payments
- Epclusa (Drug) $434.03
- Beacon (Device) $290.84
- LINX Reflux Management System (Device) $221.09
- SKYRIZI (Biological) $204.12
- OCALIVA (Drug) $137.46
- HUMIRA (Biological) $131.86
- Vemlidy (Drug) $103.74
- ENTYVIO (Biological) $87.23
- XIFAXAN (Drug) $70.29
- BioFire FilmArray (Device) $68.05
- DUPIXENT (Biological) $62.24
- XELJANZ (Drug) $54.94
- SUTAB (Drug) $44.99
- MOTOFEN (Drug) $35.77
- RINVOQ (Biological) $33.52
- Humira (Biological) $33.16
- ZEPOSIA (Drug) $23.81
- FibroScan (Device) $20.01
- LINZESS (Drug) $19.06
- XIFAXANIBSD (Drug) $18.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Annapolis
Dr. Igor Belyansky, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $645,870
Student in an Organized Health Care Education/Training Program $645,870
Juddson Chason, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,881
Student in an Organized Health Care Education/Training Program $20,881
Mary Holthaus, Pa, PA
Student in an Organized Health Care Education/Training Program — Payments: $11,376
Student in an Organized Health Care Education/Training Program $11,376
Samip Patel, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $10,231
Student in an Organized Health Care Education/Training Program $10,231
Kari Bailey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,236
Student in an Organized Health Care Education/Training Program $6,236
Sadia Shafi
Student in an Organized Health Care Education/Training Program — Payments: $4,764
Student in an Organized Health Care Education/Training Program $4,764